Supplements OTC Packaging Requirements in the US: A Complete Compliance Checklist for 2025

Bringing a dietary supplement to retail shelves in the United States involves more than formulating an effective product. Before any unit reaches a distributor warehouse or a pharmacy shelf, it must pass through a packaging process that is shaped by a layered set of federal requirements, industry conventions, and retailer expectations. These requirements are not static. They evolve alongside changes to labeling guidance, tamper-evident standards, and the FDA’s enforcement priorities. For manufacturers, contract packagers, and brand owners operating in this space, keeping current with those requirements is a practical operational concern, not just a legal formality. A packaging misstep can delay a product launch, trigger a retailer rejection, or create liability exposure that is difficult and costly to reverse.

This article walks through the primary compliance considerations for over-the-counter supplement packaging in the US as they stand heading into 2025. It is structured as a working checklist for teams involved in product development, regulatory affairs, and operations.

Understanding What Governs Supplement Packaging

Dietary supplements sold in the US are regulated under the Dietary Supplement Health and Education Act of 1994, commonly known as DSHEA, along with regulations issued by the Food and Drug Administration under its authority over food labeling and good manufacturing practices. This regulatory structure means that supplements are not regulated as drugs, but they are not treated as ordinary food either. They occupy a specific category that carries its own set of obligations, particularly around how products are identified, what claims may appear on packaging, and how those claims must be substantiated and disclosed.

When teams are planning production or evaluating vendors, understanding the full scope of supplements otc packaging requirements means looking at both federal labeling rules and the broader set of physical packaging standards that govern material safety, tamper evidence, and child resistance. Resources that consolidate regulatory and operational guidance around supplements otc packaging can help teams cross-reference requirements more efficiently during the compliance review process.

The Role of FDA and FTC in Parallel

Packaging compliance for supplements involves two federal agencies working in parallel. The FDA governs what appears on the label and how the product is manufactured and packaged. The Federal Trade Commission governs how those same claims are communicated in advertising. While the FTC’s authority technically extends beyond the package itself, the line between what appears on a label and what constitutes an advertising claim can blur, particularly for front-panel statements and structure-function claims. Teams that draft packaging copy without considering FTC guidance may find that their label language, even if it satisfies FDA requirements in isolation, creates exposure under truth-in-advertising rules.

Label Compliance: What the FDA Requires

The FDA’s labeling requirements for dietary supplements are detailed and specific. They govern the physical placement of information, the order in which it appears, and how certain terms may or may not be used. A supplement label must include a statement of identity that clearly identifies the product as a dietary supplement. It must include a net quantity of contents statement, a Supplement Facts panel in a format that follows FDA specifications, a list of all ingredients not in the Supplement Facts panel, the name and address of the manufacturer or distributor, and any required directions for use or warnings.

The Supplement Facts Panel

The Supplement Facts panel is the equivalent of the Nutrition Facts panel on food products, but it follows a distinct format specific to dietary supplements. It must list all dietary ingredients present in the product, the amount per serving, and the percent daily value where one has been established. Ingredients for which no daily value exists must still be listed, accompanied by an asterisk that directs the reader to a footnote indicating that no daily value has been established. The serving size must reflect a realistic unit of consumption, not a figure chosen for marketing purposes. Errors in the Supplement Facts panel are among the most common reasons FDA issues warning letters to supplement companies.

Structure-Function Claims and Required Disclaimers

Supplement manufacturers are permitted to make structure-function claims on their packaging. These are statements that describe how a nutrient or ingredient affects normal body function, such as noting that calcium supports bone health. What they may not do is make disease claims, which are statements that suggest a product can diagnose, treat, cure, or prevent a specific disease. Any product that makes a structure-function claim must include a specific disclaimer on the label, stating that the claim has not been evaluated by the FDA and that the product is not intended to diagnose, treat, cure, or prevent any disease. This disclaimer must appear in a specific format and placement, and its absence can constitute a labeling violation regardless of whether the underlying claim itself is accurate.

Physical Packaging Standards: Safety and Integrity

Beyond what appears on the label, the physical construction of the package must meet standards that protect consumer safety and product integrity. These standards are not optional enhancements. For many product types and distribution channels, they are mandatory requirements enforced by federal regulation, retailer policy, or both.

Tamper-Evident Packaging

The FDA requires tamper-evident packaging for over-the-counter drug products, and while dietary supplements are not classified as OTC drugs, many retailers and distributors expect tamper-evident features as a condition of placement. More importantly, if a supplement product is positioned alongside or in the same retail category as OTC drugs, the practical expectation from retail buyers is that the packaging will meet the same physical integrity standards. Tamper-evident features can include induction seals, shrink bands, breakable caps, or sealed blister packs. The specific mechanism matters less than whether it provides visible evidence of any interference before the consumer opens the product.

Child-Resistant Packaging

The Poison Prevention Packaging Act, administered by the Consumer Product Safety Commission, requires child-resistant packaging for certain categories of products. Many dietary supplements containing iron in amounts above a defined threshold are explicitly subject to these requirements, as detailed in the Consumer Product Safety Commission’s guidance on the Poison Prevention Packaging Act. Beyond regulated categories, brand owners should consider whether their product’s formulation and intended audience make child-resistant packaging a sound risk management choice even where it is not strictly mandated.

Good Manufacturing Practices and Packaging Facility Requirements

The FDA’s Current Good Manufacturing Practice regulations for dietary supplements, found in 21 CFR Part 111, establish requirements that extend directly into the packaging process. These regulations require that packaging materials be examined and tested, that packaging operations follow documented procedures, and that finished products be reviewed before release to confirm they meet established specifications. Packaging is not treated as a separate step that happens after the product leaves the manufacturing environment. It is considered part of the manufacturing process itself, subject to the same documentation, testing, and quality control requirements.

Documentation and Batch Records

Every packaging run must be supported by batch production records that capture what was packaged, what materials were used, what inspections were performed, and who approved the finished batch for release. These records are not administrative overhead. They are what allows a company to trace a problem to its source if a consumer complaint, product recall, or regulatory inspection requires it. Facilities that cannot produce complete batch records are at significant risk during FDA inspections, and gaps in packaging documentation are routinely cited in Form 483 observations.

Packaging Material Safety

Packaging materials that come into direct contact with supplement products must be suitable for that use and must not introduce contaminants. This includes the containers themselves, the closures, desiccants, and any inert gases used in the headspace. The suitability of a packaging material is not assumed simply because it is commercially available. Manufacturers are expected to have documentation confirming that contact materials do not interact with the product in ways that affect its identity, strength, quality, or purity.

Retailer and Third-Party Compliance Expectations

Federal compliance sets a floor, but major retail buyers typically impose additional requirements. These may include specific barcode formats, unit-of-measure standards, case-pack configurations, and sustainability certifications. Some retailers now require documentation confirming that supplements otc packaging materials meet defined standards for recyclability or the absence of certain chemicals. These retailer-specific requirements are not legally mandated, but failing to meet them can result in chargebacks, purchase order rejections, or removal from a retailer’s approved vendor list.

Third-Party Certification Programs

A growing number of retail buyers and institutional purchasers require that supplement products carry third-party verification from organizations such as NSF International, USP, or Informed Sport. While these programs primarily verify product content and manufacturing practices, they also carry packaging implications. Certified products must maintain specific labeling conventions that reflect the certification, and any packaging changes made after certification must be reviewed to confirm they do not conflict with certification terms.

Preparing for 2025: A Practical Compliance Checklist

Teams managing supplements otc packaging operations should work through the following checklist as part of their annual compliance review and before any product launch or packaging update.

• Confirm that the statement of identity, net quantity, and manufacturer or distributor information appear in their required positions and formats on every label.

• Verify that the Supplement Facts panel reflects current serving sizes and that all ingredient listings are accurate, complete, and formatted according to FDA specifications.

• Review all front-panel and secondary-panel claims to confirm that structure-function claims are accompanied by the required disclaimer and that no disease claims are present.

• Confirm that tamper-evident features are present and functional, and that they meet the expectations of the retail channels where the product is sold.

• Determine whether the product’s formulation triggers any child-resistant packaging obligation under the Poison Prevention Packaging Act, and document the outcome of that determination.

• Confirm that all packaging materials in direct contact with the product have documented suitability assessments on file.

• Review batch record procedures to confirm that all required documentation steps are in place for packaging operations.

• Confirm that any retailer-specific packaging requirements, including barcode standards, case configurations, and sustainability documentation, are incorporated into the production specifications.

• Review any third-party certification requirements that affect labeling or packaging format, and confirm that current packaging is in compliance with those terms.

Closing Thoughts

Supplements otc packaging compliance is not a one-time exercise. It requires ongoing attention because the regulatory environment changes, retailer expectations shift, and product formulations evolve in ways that may trigger new labeling or material obligations. The checklist above is a starting point, not a substitute for qualified regulatory counsel or a thorough internal audit process. What it can do is help teams identify gaps before they become problems and create a structured approach to the compliance review process.

The cost of getting packaging wrong in this category is rarely small. A label that contains an impermissible claim, a package that fails tamper-evident inspection, or a batch record that cannot support a recall investigation can each carry significant financial and reputational consequences. Building a rigorous, documented compliance process around packaging operations is not a response to risk. It is the most straightforward way to reduce it.